Moderna Appoints Former Executive Juan Andres to New Chief Operating Officer Role

Moderna announced it has created a new Chief Operating Officer (COO) role and appointed former executive Juan Andres to the position, effective October 5, 2026. The move is intended to support the company's increasing scale and diversification as it expands its oncology portfolio and prepares for the potential launch of its cancer vaccine, intismeran autogene.

Key Details

• Appointment: Juan Andres will return to Moderna as COO, reporting to CEO Stephane Bancel. Andres previously served as Moderna's Chief Technical Operations and Quality Officer from 2018 to 2022.
• Compensation Package: Mr. Andres will receive an annual base salary of $800,000, a target annual bonus of 90% of his salary, and a new hire equity grant valued at $5 million with a four-year vesting period.
• Executive Transition: The company also announced that Jerh Collins, Ph.D., the current Chief Technical Operations and Quality Officer, will retire from the company.